Log in or Sign up for Free to view tailored content for your specialty!
Respiratory Infections News
FDA says vaccine makers should add omicron to COVID-19 boosters
The FDA has told COVID-19 vaccine manufacturers that they should add omicron BA.4 and BA.5 variants to their existing vaccines to create bivalent boosters.
FDA advisors vote in favor of adding omicron to COVID-19 boosters
An FDA advisory committee voted Tuesday to recommend changing the composition of COVID-19 booster vaccines to include the addition of the omicron variant of SARS-CoV-2 as a component.
Log in or Sign up for Free to view tailored content for your specialty!
Recurrent childhood bronchitis linked to greater risk for pneumonia, asthma in adulthood
Recurrent episodes of childhood bronchitis appear to be associated with increased risk for lung disease later in life, researchers reported in BMJ Open Respiratory Research.
Q&A: Frequently asked questions about COVID-19 vaccines for infants, toddlers
Healio Pediatrics Editorial Board Member Leonard R. Krilov, MD, FAAP, FIDSA, FPIDS, chief of pediatric infectious diseases at NYU Langone Hospital – Long Island, answers some frequently asked questions about the vaccines.
CDC: ‘More than enough’ supplies for infant, toddler COVID-19 vaccine rollout
A White House representative said during a press conference today that “more than enough” COVID-19 vaccine doses were being distributed for the country’s 20 million infants and toddlers.
Hooked on ID with Rehan Syed, MD, MSc
In retrospect, my path to infectious diseases began before I recognized it.
ACIP recommends enhanced flu vaccines for older Americans, adds MMR vaccine
The CDC’s Advisory Committee on Immunization Practices voted unanimously on Wednesday to recommend enhanced influenza vaccines for older Americans, introduce a second MMR vaccine, and OK a 15-valent pneumococcal vaccine for children.
FDA approves 15-valent pneumococcal vaccine for children
Merck announced Wednesday that the FDA approved an expanded indication for Vaxneuvance, the company’s 15-valent pneumococcal conjugate vaccine, to include its use in infants and children aged 6 weeks to 17 years.
Q&A: The science behind long COVID symptoms
New research seems to help explain the biology behind long COVID symptoms like brain fog and increased anxiety and depression.
Study finds Paxlovid reduces risk for severe COVID-19, death by 46%
Paxlovid lowered the risk for severe COVID-19 or death by 46% in a study of patients in Israel and was especially effective among older or immunosuppressed patients, or patients with underlying neurological or cardiovascular diseases.
-
Headline News
VIDEO: If you want the health benefits of infrared light, ‘you’ve got to get outside’
September 23, 20248 min watch -
Headline News
FDA OKs Bimzelx for psoriatic arthritis, ankylosing spondylitis, non-radiographic axSpA
September 23, 20243 min read -
Headline News
Early childhood exposure to more green spaces linked to improved lung function
September 24, 20242 min read
-
Headline News
VIDEO: If you want the health benefits of infrared light, ‘you’ve got to get outside’
September 23, 20248 min watch -
Headline News
FDA OKs Bimzelx for psoriatic arthritis, ankylosing spondylitis, non-radiographic axSpA
September 23, 20243 min read -
Headline News
Early childhood exposure to more green spaces linked to improved lung function
September 24, 20242 min read